Supporting prostate cancer research

Current Research Projects

Our research covers the physical, psychosocial, and financial issues of cancer, beyond the diagnosis and treatment phases and includes issues related to the ability to get health care and follow-up treatment, late effects of treatment, second cancers, and quality of life. Family members, friends, and caregivers are also included in our research.

Exploring men’s experiences and needs regarding vocational rehabilitation, work and retirement after prostate cancer diagnosis.

Previous research has found that returning to work after a cancer diagnosis can improve people’s quality of life and psychological wellbeing, while also lessening the economic burden associated with the diagnosis.


SafeHealthApps: Monitoring the safety of health apps.

Mobile apps are increasingly being used to engage consumers to participate in their healthcare. The number of health apps has soared in the past few years with around 165,000 currently available in the Apple iTunes and Android app stores.


Navigate: Randomised Control Trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.

Men recently diagnosed with low risk prostate cancer are needed to take part in a study assessing a new online tool designed to help navigate their treatment. The Navigate clinical trial is recruiting men diagnosed with low-risk or localised prostate cancer within the last three months.


Prostate Cancer Health and Fitness Online: The development and pilot testing of an internet physical activity program for prostate cancer survivors.

Research has shown that participating in physical activity is beneficial for prostate cancer survivors. Some men have expressed interest to use the internet as a way to find information on their own. This study asks whether an internet program could be a good way for men to receive information about physical activity.


The role of subjective cognition in the link between cancer and well-being

You are invited to participate in a study about the impact of social and practical support, fatigue and job demand on returning to work following cancer. Your experiences will help us improve the lives of other people with cancer.


TheraP: A randomised phase 2 trial of 177Lu-PSMA617 theranostic versus cabazitaxel in progressive metastatic castration resistant prostate cancer.

Lutetium-177 PSMA radionuclide therapy (Lu-PSMA) is a new treatment for advanced prostate cancer. Lu-PSMA is a radioactive molecule that specifically attaches to cells with high amounts of PSMA on the surface of the cells.


Weight loss programme for prostate cancer patients.

Androgen deprivation therapy (ADT) is a common treatment for prostate cancer. One of the many possible side effects of this treatment is weight gain. Lifestyle changes utilising exercise and diet have been demonstrated as safe and result in improved health, physical function, and quality of life for cancer patients. The purpose of this study is to assess the efficacy of an exercise and diet programme designed to induce weight loss.


Cancer-related follow-up care survey for cancer survivors

It is important for cancer survivors to look after their health in the months and years following their treatment for cancer. During this time, many cancer survivors benefit from information and support across a range of areas. We would like to learn more about your experience with follow-up care, particularly regarding the information you have received about the care you need in the future.


Evaluating health behaviours and beliefs in childhood cancer survivors, adult cancer survivors and healthy Australians.

Advances in cancer screening and treatment have led to improved 5-year survival rates, particularly among prostate cancer survivors. Little is known about the health behaviours of Australian cancer survivors. Health behaviours are activities undertaken by an individual for the purpose of promoting, protecting or maintaining health.


Advanced Prostate Cancer Patient Value Mapping Study

Community and Patient Preference Research (CaPPRe) is working with Prostate Cancer Foundation of Australia to conduct research with men who have metastatic prostate cancer.


Join us today!

Pathfinder is a unique prostate cancer research register that enables prostate cancer survivors to participate in research for a brighter future with their loved ones.

It will enable researchers to save valuable time and money recruiting participants for their projects, so that they can spend more time delivering health benefits to those in need. Click the button to the right to register!